Wealth Enhancement Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.4M | Buy |
131,408
+4,258
| +3% | +$1.83M | 0.09% | 207 |
|
|
2025
Q1 | $63.3M | Sell |
127,150
-122
| -0.1% | -$60.7K | 0.12% | 166 |
|
|
2024
Q4 | $66.2M | Buy |
127,272
+1,556
| +1% | +$809K | 0.13% | 157 |
|
|
2024
Q3 | $77.8M | Buy |
125,716
+656
| +0.5% | +$406K | 0.17% | 123 |
|
|
2024
Q2 | $69.2M | Sell |
125,060
-528
| -0.4% | -$292K | 0.16% | 128 |
|
|
2024
Q1 | $73M | Sell |
125,588
-869
| -0.7% | -$505K | 0.19% | 113 |
|
|
2023
Q4 | $67.1M | Buy |
126,457
+1,378
| +1% | +$731K | 0.2% | 117 |
|
|
2023
Q3 | $63.3M | Buy |
125,079
+123,379
| +7,258% | +$62.5M | 0.21% | 109 |
|
|
2023
Q2 | $887K | Buy |
1,700
+130
| +8% | +$67.8K | 0.01% | 277 |
|
|
2023
Q1 | $905K | Buy |
+1,570
| New | +$905K | 0.01% | 315 |
|
|
2022
Q4 | – | Sell |
-11,048
| Closed | -$5.78M | – | 366 |
|
|
2022
Q3 | $5.78M | Buy |
+11,048
| New | +$5.78M | 0.08% | 113 |
|
|
2021
Q3 | – | Sell |
-7,866
| Closed | -$4.05M | – | 339 |
|
|
2021
Q2 | $4.05M | Buy |
7,866
+5,676
| +259% | +$2.92M | 0.07% | 113 |
|
|
2021
Q1 | $1.03M | Buy |
2,190
+182
| +9% | +$85.3K | 0.02% | 195 |
|
|
2020
Q4 | $1.01M | Buy |
+2,008
| New | +$1.01M | 0.02% | 166 |
|
|
2019
Q3 | – | Sell |
-6,113
| Closed | -$1.77M | – | 240 |
|
|
2019
Q2 | $1.77M | Buy |
+6,113
| New | +$1.77M | 0.08% | 105 |
|